ROSSINI, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 23.867
EU - Europa 22.820
AS - Asia 16.719
SA - Sud America 2.218
AF - Africa 459
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 17
Totale 66.141
Nazione #
US - Stati Uniti d'America 23.460
RU - Federazione Russa 7.720
SG - Singapore 7.053
GB - Regno Unito 5.406
CN - Cina 4.566
IT - Italia 2.857
BR - Brasile 1.749
HK - Hong Kong 1.464
DE - Germania 1.404
VN - Vietnam 1.359
FR - Francia 1.265
SE - Svezia 1.112
IE - Irlanda 1.064
FI - Finlandia 869
KR - Corea 558
BD - Bangladesh 341
IN - India 321
UA - Ucraina 315
TR - Turchia 230
JP - Giappone 203
CA - Canada 202
NL - Olanda 169
AR - Argentina 168
NG - Nigeria 131
MX - Messico 123
PL - Polonia 113
ES - Italia 107
IQ - Iraq 104
ID - Indonesia 95
ZA - Sudafrica 84
BE - Belgio 80
AT - Austria 76
EC - Ecuador 71
CO - Colombia 58
CL - Cile 49
PK - Pakistan 48
RO - Romania 47
UZ - Uzbekistan 47
TG - Togo 43
VE - Venezuela 42
BJ - Benin 39
MA - Marocco 37
IR - Iran 36
SA - Arabia Saudita 34
AU - Australia 33
NP - Nepal 27
PY - Paraguay 27
EG - Egitto 26
KE - Kenya 25
PE - Perù 25
PH - Filippine 25
IL - Israele 23
CH - Svizzera 22
LT - Lituania 21
MY - Malesia 20
CZ - Repubblica Ceca 19
JO - Giordania 19
AZ - Azerbaigian 18
GR - Grecia 18
AE - Emirati Arabi Uniti 17
DZ - Algeria 16
JM - Giamaica 15
PT - Portogallo 15
TN - Tunisia 15
BG - Bulgaria 13
BO - Bolivia 13
HR - Croazia 13
SK - Slovacchia (Repubblica Slovacca) 13
DO - Repubblica Dominicana 12
CR - Costa Rica 11
KG - Kirghizistan 11
LB - Libano 11
OM - Oman 11
UY - Uruguay 11
AL - Albania 9
RS - Serbia 9
BH - Bahrain 8
EU - Europa 8
LV - Lettonia 8
NO - Norvegia 8
PS - Palestinian Territory 8
QA - Qatar 8
SN - Senegal 8
DK - Danimarca 7
HN - Honduras 7
SI - Slovenia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AM - Armenia 6
ET - Etiopia 6
GT - Guatemala 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PA - Panama 6
SV - El Salvador 6
TH - Thailandia 6
BY - Bielorussia 5
KW - Kuwait 5
SY - Repubblica araba siriana 5
BW - Botswana 4
CI - Costa d'Avorio 4
Totale 66.036
Città #
Southend 4.776
Singapore 3.765
Ashburn 2.674
Moscow 2.468
Jacksonville 2.237
Chandler 2.205
San Jose 2.183
Dallas 1.795
Hong Kong 1.436
Woodbridge 1.234
Dublin 1.047
Ann Arbor 959
Verona 799
The Dalles 724
Beijing 708
Houston 698
Council Bluffs 532
New York 481
Los Angeles 463
Ho Chi Minh City 451
Lawrence 447
Princeton 447
Wilmington 424
Jinan 329
Nanjing 297
Hanoi 292
Shenyang 281
Redmond 238
Buffalo 237
Milan 216
Bologna 215
Helsinki 215
Tokyo 184
Tianjin 182
Sindelfingen 178
Hebei 175
Munich 167
São Paulo 161
Redondo Beach 159
Santa Clara 143
Changsha 136
Columbus 129
Abuja 128
Rome 114
Ningbo 113
Zhengzhou 113
Boardman 112
Haikou 109
Nanchang 108
Hangzhou 96
Orem 94
Warsaw 94
London 93
Jiaxing 90
Guangzhou 88
Taizhou 88
Seattle 87
Chicago 81
Denver 77
San Francisco 77
Redwood City 72
Brussels 69
Frankfurt am Main 69
Taiyuan 69
Norwalk 66
Falkenstein 65
Brooklyn 61
Washington 61
Montreal 58
Toronto 58
Turku 58
Phoenix 56
Da Nang 55
Johannesburg 52
Chennai 51
Falls Church 51
Amsterdam 50
Atlanta 50
Hyderabad 49
Rio de Janeiro 49
Belo Horizonte 48
Fairfield 48
Brasília 45
Tashkent 45
Vienna 45
Boston 44
Jakarta 44
Stockholm 44
Fuzhou 43
Lomé 43
Dearborn 42
Lanzhou 42
Manchester 42
Biên Hòa 41
Dong Ket 41
Mexico City 40
Orani 40
Cotonou 39
Poplar 39
Seoul 39
Totale 40.672
Nome #
Epidemiology and Economic Burden of Osteoporosis in Italy 446
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 424
Teriparatide and denosumab combination therapy and skeletal metabolism 348
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 333
Artrite Reumatoide e Metabolismo Minerale 271
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 271
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 271
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 267
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 265
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 255
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 254
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 245
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 243
Anti-CCP antibodies and bone 242
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 238
Age-related bone loss in postmenopausal women 237
[Therapeutic strategies in osteoporosis: whom and when to treat] 233
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 233
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 230
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 229
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 227
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 226
Bone metabolism in patients with anorexia nervosa and amenorrhoea 226
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 222
[Risk factors for hip fracture in elderly persons]. 220
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 215
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 214
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 214
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 210
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 210
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 209
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 208
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 207
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 207
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 206
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 205
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 204
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 203
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 203
Bone involvement and osteoporosis in mastocytosis. 203
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 203
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 201
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 201
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 199
Incidenza di ipovitaminosi D nel Nord Italia 198
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 198
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 196
Prevalence and incidence of rheumatoid arthritis in Italy. 191
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 191
Bone involvement in patient with clonal mast cell disorders 190
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 190
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 188
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 187
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 187
Could γ\δ T-cells explain zoledronic acid adverse events? 186
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 185
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 184
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 184
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 182
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
The obesity paradox and osteoporosis 179
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 179
Allergy and the bone: unexpected relationships 178
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 178
Osteopetrosi 177
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 177
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 176
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 176
Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases. 175
Guidelines for the diagnosis, prevention and management of osteoporosis 175
Osteoporosis treatment: why ibandronic acid? 173
Rapporti tra sistema immune e metabolismo osseo 172
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 172
A multi-dimensional questionnaire quantifying quality of life in elderly osteoporotic women: the Italian triple-Q osteoporosis study 171
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Bone Disease in Mastocytosis 171
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 170
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 170
ARTROPATIE DISMETABOLICHE 170
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 170
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 170
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 167
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 167
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 167
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 167
DXA bone mineral density in males: retrospective study in real life. 166
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 166
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 165
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 165
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 165
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 165
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 164
Sclerostin and DKK1 in primary hyperparathyroidism. 164
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 164
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 164
Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis 163
Effects of denosumab on peripheral lymphocyte subpopulations 163
Totale 20.431
Categoria #
all - tutte 230.582
article - articoli 220.678
book - libri 0
conference - conferenze 3.223
curatela - curatele 0
other - altro 680
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.001
Totale 461.164


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 0 0 0 0 0 0 158
2021/20223.269 238 807 49 158 155 128 61 185 278 97 305 808
2022/20236.835 560 555 703 1.180 607 1.652 86 384 732 75 226 75
2023/20243.514 179 270 330 418 403 534 180 274 58 128 494 246
2024/20259.554 564 679 406 1.475 472 257 444 469 1.414 810 701 1.863
2025/202627.151 1.946 1.344 1.991 4.359 6.477 1.888 2.731 1.610 2.046 1.298 606 855
Totale 66.927